Vestara and MedClean Technologies Announce Co-Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management

Share Article

Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste. Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste.

Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Vestara's EcoRex® Automated Pharmaceutical Waste Management System utilizes barcode technology already widely used in hospitals to track drug utilization that prevents medication errors and a proprietary, continuously updated database of more than 180,000 National Drug Code (NDC) products, to instantly categorize pharmaceutical waste at time of presentation. By automating the identification and sorting of different types of residual drugs, empty containers, and each hospital's unique admixtures, EcoRex® eliminates the human error and potential cross contamination inherent in manual sorting of pharmaceutical waste to reduce negative impact on the environment. Just as important, relevant data and an audit trail are provided in the form of comprehensive reports for client records.

MedClean® Series Systems enable hospitals and other medical facilities to treat and dispose of their RMW stream and provide HIPAA-compliant destruction of confidential documents in an efficient, compliant, safe and cost-effective manner. MedClean provides a state-of-the-art on-site treatment solution for each end user through its full line of On-Demand Container, Mobile and in-house, fixed systems. MedClean's solutions provide significant advantages for hospital customers compared to other approaches, including lower costs, reduced risk and protection of host communities and the overall environment. A single MedClean Container system can treat 1 million pounds of RMW per year, in addition to handling confidential document destruction, with a smaller footprint required compared to multiple vendors handling different tasks for a hospital.

Working together, Vestara and MedClean bring unique technologies to a common customer base, addressing the toughest waste mitigation issues facing hospitals today.

Please visit booth # 419 at the 2009 ASHES Conference in Reno, NV, September 21-22, 2009, to learn more about the Vestara-MedClean Technologies partnership.

About Vestara
Vestara, headquartered in Irvine, CA, provides proprietary technology to automatically identify, sort, and segregate hazardous and non-hazardous pharmaceutical waste into proper waste streams. Vestara's solutions not only assure clients will be compliant with all federal and state laws, but that they will experience a more efficient health system workforce and true cost savings in managing pharmaceutical waste. Most importantly, clients will play a critical role in preserving our precious environment. To learn more, visit http://www.vestara.com.

About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at http://www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at http://www.sec.gov.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

James Kim
Vestara
949-660-8648 ext. 232
Email >
Visit website